According to Onconova Therapeutics's latest financial reports the company has a price-to-book ratio of 92.4986.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 1.47 | 207.44% |
2022-12-31 | 0.4773 | -58.68% |
2021-12-31 | 1.16 | -91.72% |
2020-12-31 | 14.0 | 279.25% |
2019-12-31 | 3.68 | 65.52% |
2018-12-31 | 2.22 | -249.4% |
2017-12-31 | -1.49 | -149.7% |
2016-12-31 | 2.99 | 33.16% |
2015-12-31 | 2.25 | -25.64% |
2014-12-31 | 3.02 | -0.77% |
2013-12-31 | 3.05 | |
2012-12-31 | N/A |